Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health, Office of Infectious Disease Policy.
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services is hereby giving notice that a meeting is scheduled to be held for the National Vaccine Advisory Committee (NVAC). The meeting will be open to the public; public comment sessions will be held during the meeting.
The meeting will be held on September 17 and 18, 2019. The meeting times and agenda will be posted on the NVAC website at https://www.hhs.gov/vaccines/nvac/meetings/index.html as soon as they become available.
U.S. Department of Health and Human Services, Hubert H. Humphrey Building, The Great Hall, 200 Independence Avenue SW, Washington, DC 20201.
The meeting can also be accessed through a live webcast on both days of the meeting. For more information, visit https://www.hhs.gov/webforms/nvac/index.html.
Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in a public comment session. Individuals who wish to attend the meeting and/or participate in a public comment session should register at https://www.hhs.gov/webforms/nvac/index.html. Participants may also register by emailing email@example.com or by calling (202) 795-7697 and providing their name, organization, and email address.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ann Aikin, Acting Designated Federal Officer, Office of Infectious Disease Policy, U.S. Department of Health and Human Services, Room L001, Switzer Building, 330 C Street SW, Washington, DC 20201. Phone: (202) 795-7697; email: firstname.lastname@example.org.
End Further Info
Start Supplemental Information
Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve Start Printed Page 46550optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program's responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program.
During the September 2019 NVAC meeting, sessions will consist of presentations on immunization equity, immunity, vaccines for small populations and uncommon diseases, and influenza safety monitoring, and evidence-based tools for improving influenza vaccination efforts. Please note that agenda items will be related to the charges of the Committee and are subject to change as priorities dictate. Information on the final meeting agenda will be posted prior to the meeting on the NVAC website: https://www.hhs.gov/vaccines/nvac/meetings/index.html.
Public attendance at the meeting is limited to the available space. Individuals who plan to attend in person and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Office of Infectious Disease Policy at the address/phone number listed above at least one week prior to the meeting. For those unable to attend in person, a live webcast will be available. More information on registration and accessing the webcast can be found at https://www.hhs.gov/vaccines/nvac/meetings/index.html.
Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit their written comments. Written comments should not exceed three pages in length. Individuals submitting written comments should email their comments to the Office of Infectious Disease Policy (email@example.com) at least five business days prior to the meeting.
End Supplemental Information
Dated: August 16, 2019.
Acting Designated Federal Officer, Office of Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2019-19201 Filed 9-3-19; 8:45 am]
BILLING CODE 4150-44-P